Most drugs simply
do not work for most people!
Our Solution
AI-Driven
RNA precision blood test
Delivering cutting-edge scientific services with precise testing, research support, and consultation, committed to excellence and advancement in every project.
Led by passionate experts- 98.3% accuracy
- Predicts patient response to treatments
- Prevents unnecessary suffering and cost
Our Journey
Early 2000s
• Work at Brigham Women's Hospital
• Gain experience in retail and hospital pharmacy settings
• Transitions to academia
• Working at Boston Medical Center
• Gain experience in retail and hospital pharmacy settings
• Transitions to academia
• Working at Boston Medical Center
Mid 2000s
• Clear challenges in clinical practice become apparent, especially with antidepressants
• Uncertainty in medical recommendations and reliance on anecdotal evidence highlighted
Early 2010s
• Advent of AI in healthcare presents new opportunities
• Concept of precision medicine becomes more tangible with AI applications
• Concept of precision medicine becomes more tangible with AI applications
2015 - 2020
• Meet Patrick with Liquid Biosciences, who introduces the breakthrough in evolutionary AI in identifying novel biomarkers in RNA
• Decision to form Ignite is made, driven by collective experiences and AI potential
• Initial excitement & validation from clinicians and industry experts
• Aim to obtain Clinical Laboratory Improvement Amendment (CLIA) certification
Pre-Launch Activities
2021 - Present
• First round of funding is successful
• Positive reception from investors despite challenging economic environment
• Developed test
• Procured successful analytical validation for TNFi predictive response
•
• Positive reception from investors despite challenging economic environment
• Developed test
• Procured successful analytical validation for TNFi predictive response
•
What our Partner's say
Patrick Lilley
CEO Liquid Bioscience
Quote from Patrick
Kimberly Baldwin
SVP IPSEN
Kim Quote
Joseph Boswell
Founder
Joe quote
.png)